| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2004 | WO2004026816B1 Aromatic liver x-receptor modulators |
| 07/29/2004 | WO2004026285A3 Compositions and methods for treating heart disease |
| 07/29/2004 | WO2004024889A3 Production of bispecific molecules using polyethylene glycol linkers |
| 07/29/2004 | WO2004024153A3 Calcium channel blockers |
| 07/29/2004 | WO2004024093A3 Device and method for treating restenosis |
| 07/29/2004 | WO2004022001A3 Compositions and methods for inhibiting proliferation in human prostate cancer cells |
| 07/29/2004 | WO2004021997A8 Inhibitors of fungal invasion |
| 07/29/2004 | WO2004021996A3 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 07/29/2004 | WO2004020631A3 Genetic suppression and replacement |
| 07/29/2004 | WO2004019910A3 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 07/29/2004 | WO2004019879A8 Motilide compounds |
| 07/29/2004 | WO2004018419B1 Benzimidazole quinolinones and uses thereof |
| 07/29/2004 | WO2004017971A8 Use of a papaverine-like vasodilator and pharmaceutical composition |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | WO2004013091A3 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 07/29/2004 | WO2004011626A3 Assays and methods based on microcompetition with a foreign polynucleotide |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2004002403A3 Sterols bearing pendant allosteric effectors of hemoglobin, and uses thereof |
| 07/29/2004 | WO2003105811A3 Controlled release compositions and methods for using same |
| 07/29/2004 | WO2003104181A3 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 07/29/2004 | WO2003102158A3 Methods for increasing bone density |
| 07/29/2004 | WO2003101382A3 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 07/29/2004 | WO2003099783A3 Tropane compounds |
| 07/29/2004 | WO2003096982A3 Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003094850A3 Lipid a and other carbohydrate ligand analogs |
| 07/29/2004 | WO2003092622A3 Carvedilol monocitrate monohydrate |
| 07/29/2004 | WO2003092621A3 Composition and method for dermatological treatment |
| 07/29/2004 | WO2003082262A3 Compositions of venlafaxine base |
| 07/29/2004 | WO2003078367A3 Benzyl alcohol derivatives and their use as antimicrobial agents |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003060067A3 P85-alpha nucleic acids, polypeptides and related methods |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003059355A8 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/29/2004 | WO2003057223A8 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | WO2003037295A3 Micelle compositions containing pegylated phospholipids and a photosensitizer |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | WO2002069883A3 Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders |
| 07/29/2004 | US20040148644 Method for generating overexpression of alleles in genes of unknown function |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147788 Stilbene derivatives and their use as aryl hydrocarbon receptor antagonistic ligands |
| 07/29/2004 | US20040147767 Separation of plants and agitation to form natural products from cannabis plant material after decarboxylation |
| 07/29/2004 | US20040147754 Novel process |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147744 2-(N-cyano-N-methylamino)-4-chloro-5-(2,4,6-trifluorophenyl)-6-(1,1,1-trifluoroprop-2-ylamino)-pyrimidine; synthesis; treating plant locus |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147737 cellulose ether esters of lactic acid and of hydroxyacetic acid; slow-release pharmaceutical preparations |
| 07/29/2004 | US20040147729 useful as agents for the prevention or treatment of diabetes, diabetic complications or obesity; inhibitory activity in human SGLT2 |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147714 High linear content; low molecular weight, narrow range; using alkali metal secondary amine polymerization aide |
| 07/29/2004 | US20040147673 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 07/29/2004 | US20040147616 Immersion foot in alcohol solution containing drug; drug penetration skin |
| 07/29/2004 | US20040147614 Serotonin receptor antagonist; administering reboxetine; psychological disorders |
| 07/29/2004 | US20040147613 Synergistic mixture; blocking neurotransmitters; dopamine receptors; haloperidol and (meth)amphetamine |
| 07/29/2004 | US20040147610 Aging resistance; anticancer agents; neurodegradation disease;amyotropic lateral sclerosis; Alzheimer's disease |
| 07/29/2004 | US20040147609 Liquid drug preparations |
| 07/29/2004 | US20040147607 Storage stability |
| 07/29/2004 | US20040147606 Medicinal compositions |
| 07/29/2004 | US20040147605 Mixture of antitussive agent and fudosteine |
| 07/29/2004 | US20040147604 Using keto carboxylic acid salt alone , or with creatine, nicotinamide ; antiulcer agents; antihistamines; skin disorders; anticancer agents |
| 07/29/2004 | US20040147603 Malic acid addition salts of terbinafine |
| 07/29/2004 | US20040147602 Mixed esters of dicarboxylic acids for use as pigment dispersants |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147599 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/29/2004 | US20040147598 Cardiovascular disorders; angina pectoris |
| 07/29/2004 | US20040147597 Anti-mycobacterium compositions and methods of preparing and using same |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147595 Biofilm degrading or sloughing compositions and methods |
| 07/29/2004 | US20040147594 Compositions and products containing R-equol, and methods for their making |
| 07/29/2004 | US20040147593 Eating disorders; sleep disorders; obesity |
| 07/29/2004 | US20040147590 Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors |
| 07/29/2004 | US20040147589 Indolone derivatives having vascular damaging activity |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147585 Bis(indol-3-yl)acetic acid ,or ester thereof; drug or cosmetic |
| 07/29/2004 | US20040147583 Anxiolytic agents; Alzheimer's disease |
| 07/29/2004 | US20040147582 Use of etodolac for the treatment of chronic lymphocytic leukemia |
| 07/29/2004 | US20040147581 Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147579 Antiinflammatory agents; antiarthritic agents; antihistamines; respiratory system disorders; glomerulonephitis; inflammatory bowel disorders; Crohn's disease; skin disorders; tumor necrosis factor sensitive disease |
| 07/29/2004 | US20040147577 Heterocyclic compounds |
| 07/29/2004 | US20040147576 Cardiovascular disorders; thrombosis; anticoagulants |
| 07/29/2004 | US20040147575 Hypotensive agents; cardiovascular disorders |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147572 Novel pyrrolyl-thiazole derivatives |
| 07/29/2004 | US20040147571 Substituted oxazoles and thiazoles as hppar alpha agonists |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147568 Obesity; dietetics; adjust density of bones, muscles |
| 07/29/2004 | US20040147567 Control appetites; obesity; eating disorders |
| 07/29/2004 | US20040147566 Lisinopril/lercanidipine combination therapy |
| 07/29/2004 | US20040147565 Antiinflamamtory agents; analgesics; antipyretics |
| 07/29/2004 | US20040147563 Use of thiazole deirvatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147557 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147555 Anticoagulants; brain disorders; blood circulation disorders; myocardial infraction |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |